These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11234674)

  • 1. [Gene transfer immunotherapy in rheumatoid arthritis: perspectives].
    Jorgensen C
    Rev Med Interne; 2001 Feb; 22(2):163-71. PubMed ID: 11234674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].
    Mugnier B; Bouvenot G
    Rev Med Interne; 2000 Oct; 21(10):854-62. PubMed ID: 11075394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy in rheumatoid arthritis; current status].
    Breedveld FC; van de Putte LB
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1255-9. PubMed ID: 8700279
    [No Abstract]   [Full Text] [Related]  

  • 5. New therapeutic targets in rheumatoid arthritis.
    Jorgensen C
    Joint Bone Spine; 2000; 67(4):277-82. PubMed ID: 10963074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene therapy in rheumatoid polyarthritis: perspectives].
    Bessis N; Boissier MC
    Presse Med; 1998 Mar; 27(12):580-2. PubMed ID: 9767955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine blockade in rheumatoid arthritis.
    Feldmann M; Maini RN; Bondeson J; Taylor P; Foxwell BM; Brennan FM
    Adv Exp Med Biol; 2001; 490():119-27. PubMed ID: 11505970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigational treatments in rheumatoid arthritis.
    Breedveld FC
    Baillieres Best Pract Res Clin Rheumatol; 1999 Dec; 13(4):701-18. PubMed ID: 10652649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of gene therapy for rheumatoid arthritis.
    Gaddy DF; Robbins PD
    Curr Rheumatol Rep; 2008 Oct; 10(5):398-404. PubMed ID: 18817645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of anti-TNF-alpha molecules in inflammatory and infectious diseases].
    Fautrel B; Cherin P
    Rev Med Interne; 2000 Oct; 21(10):872-88. PubMed ID: 11075396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects of immunotherapy for rheumatoid arthritis.
    t Hart BA; Otten HG
    Pharm World Sci; 1995 Nov; 17(6):178-85. PubMed ID: 8597773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis.
    Liu X; Zhou H; Huang X; Cui J; Long T; Xu Y; Liu H; Yu R; Zhao R; Luo G; Huang A; Liang JG; Liang P
    J Immunol; 2016 Oct; 197(8):3029-3037. PubMed ID: 27619991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental therapy of rheumatoid arthritis with antibodies to tumor necrosis factor].
    Manger B
    Z Rheumatol; 1998 Oct; 57(5):298-301. PubMed ID: 9864834
    [No Abstract]   [Full Text] [Related]  

  • 14. TNF alpha is an effective therapeutic target for rheumatoid arthritis.
    Feldmann M; Brennan FM; Elliott MJ; Williams RO; Maini RN
    Ann N Y Acad Sci; 1995 Sep; 766():272-8. PubMed ID: 7486670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy of rheumatoid arthritis via cytokine regulation: future perspectives.
    Chernajovsky Y; Feldmann M; Maini RN
    Br Med Bull; 1995 Apr; 51(2):503-16. PubMed ID: 7552079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of TNF-α with a focus on rheumatoid arthritis.
    Moelants EA; Mortier A; Van Damme J; Proost P
    Immunol Cell Biol; 2013 Jul; 91(6):393-401. PubMed ID: 23628802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
    Feldmann M; Brennan F; Paleolog E; Taylor P; Maini RN
    Eur Cytokine Netw; 1997 Sep; 8(3):297-300. PubMed ID: 9346366
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry.
    Caporali R; Sarzi-Puttini P; Atzeni F; Gorla R; Filippini M; Marchesoni A; Favalli EG; Bobbio-Pallavicini F; Montecucco C
    Autoimmun Rev; 2010 Apr; 9(6):465-9. PubMed ID: 20044040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for rheumatoid arthritis. Theoretical considerations.
    Chernajovsky Y; Annenkov A; Herman C; Triantaphyllopoulos K; Gould D; Dreja H; Moyes SP; Croxford JL; Mageed RA; Podhajcer OL; Baker D
    Drugs Aging; 1998 Jan; 12(1):29-41. PubMed ID: 9467685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging cytokine targets in rheumatoid arthritis.
    Asquith DL; McInnes IB
    Curr Opin Rheumatol; 2007 May; 19(3):246-51. PubMed ID: 17414950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.